Rolf Wachter
Wachter, Rolf 1973-
VIAF ID: 62465063 (Personal)
Permalink: http://viaf.org/viaf/62465063
Preferred Forms
- 100 0 _ ‡a Rolf Wachter
- 100 1 _ ‡a Wachter, Rolf ‡d 1973-
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Aktualisierte ESC-Leitlinie: Pharmakotherapie der chronischen Herzinsuffizienz Epidemiologie und Krankheitsbild, Pathophysiologie und Risikofaktoren, ESC-Therapiealgorithmus | |
Antiarteriosklerotische Eigenschaften von Nifedipin in der Gefäßwand - ein kalziumantagonistischer Effekt? | |
Decreased caveolin-1 in atheroma: loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis. | |
Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD). | |
Diagnostik und Therapie der diastolischen Herzinsuffizienz 22 Tabellen | |
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial. | |
Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany. | |
Early pneumonia and timing of antibiotic therapy in patients after nontraumatic out-of-hospital cardiac arrest | |
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs | |
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial | |
Einfluss der Interleukin-6 Inhibition auf die kardiale Funktion transgener herzinsuffizienter Mäuse | |
Elevated serum levels of interleukin-10 and tumor necrosis factor α [corrected] are both associated with vital exhaustion in patients with cardiovascular risk factors. | |
Expert opinion paper on atrial fibrillation detection after ischemic stroke. | |
Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring--Find-AF(RANDOMISED) --rationale and design | |
[GDF-15, MRproADM, CTproET1, and CTproAVP in patients with asymptomatic diastolic dysfunction]. | |
Heart failure awareness survey in Germany: general knowledge on heart failure remains poor | |
Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System | |
Heart failure is independently associated with white matter lesions: insights from the population‐based LIFE‐Adult Study | |
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy | |
[Heart or brain? Problem patients at the interface between cardiology and neurology]. | |
High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia. | |
Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. | |
Impact of baroreflex activation therapy on renal function--a pilot study | |
Impact of obstructive sleep apnoea on diastolic function | |
impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM‐CHF randomized controlled trial | |
Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. | |
Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction. | |
[Importance of surfactant proteins B and D for the differential diagnosis of acute dyspnea] | |
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease | |
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens. | |
[Interventional strategies in hypertension management]. | |
[Invasive treatment of hypertension : Update 2016]. | |
Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function | |
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study | |
Letter by Wachter et al regarding article, "occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors" | |
Long term biventricular support with Berlin Heart Excor in a Septuagenarian with giant-cell myocarditis. | |
Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care | |
[Neurohormonal activation and maximal exercise capacity in diastolic dysfunction and diastolic heart failure]. | |
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure | |
Plasma mid-regional pro-adrenomedullin levels are inversely associated with anxiety but unrelated to depression: Results from the observational DIAST-CHF study in patients with cardiovascular risk factors. | |
Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure. | |
[Pulmonary hypertension associated with left heart disease: recommendations of the Cologne Consensus Conference 2016] | |
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research. | |
Quantification of left atrial volume and phasic function using cardiovascular magnetic resonance imaging-comparison of biplane area-length method and Simpson's method. | |
[A rare cause of right heart failure]. | |
Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan. | |
Recommendations for the treatment of heart failure : What's new? | |
Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure. | |
Relevance of supraventricular runs detected after cerebral ischemia. | |
Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II | |
Reverse epidemiology in different stages of heart failure | |
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. | |
A risk score to predict future atrial fibrillation derived from patients with stroke initially presenting with atrial fibrillation? | |
Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin. | |
The role of atrial fibrillation in patients with an embolic stroke of unknown source (ESUS). | |
Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertension. | |
Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life | |
Screening for mental disorders in heart failure patients using computer-adaptive tests. | |
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration | |
Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure | |
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. | |
A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure | |
Subclinical atrial fibrillation: how hard should we look? | |
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction. | |
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial | |
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial | |
Transthoracic echocardiography to rule out paroxysmal atrial fibrillation as a cause of stroke or transient ischemic attack. |